Shanrong Biotechnology (SRBT, $0.31) was a top loser this month, diving -5 to $0.31 per share. Of the 184 stocks analyzed in the Financial Conglomerates Industry throughout this month, of them (7) exhibited an Uptrend while of them (2) were in a Downtrend.